Ms. Beverly Sue Mckean, REGISTERED NURSE Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: 809 Grove Ave, Holly Hill, FL 32117 Phone: 386-675-5274 |
Jacqueline Marie Awoyale, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1615 Ridgewood Ave Ste 101, Holly Hill, FL 32117 Phone: 386-868-5900 |
Wendy Outinen, RNFA Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 1700 Birmingham Ave, Holly Hill, FL 32117 Phone: 386-566-0769 |
News Archive
GPC Biotech AG has announced that the Oncologic Drugs Advisory Committee (ODAC) for the U.S. Food and Drug Administration (FDA) recommended (12-0) that the FDA should wait for the final survival analysis of the SPARC trial before deciding whether the satraplatin application is approvable for the treatment of hormone-refractory prostate cancer patients whose prior chemotherapy has failed.
Media are invited to participate in the science and technology tours being held in conjunction with the Pittsburgh G-20 Summit Sept. 24-25. Twelve one-hour tours—hosted by the University of Pittsburgh, Carnegie Mellon University, and the University of Pittsburgh Medical Center—are being offered on Monday, Sept. 21. They will highlight the science and technology that is driving the region's economy.
UT Southwestern Medical Center has joined a national clinical trial to identify the long-term health effects of West Nile virus infection and to learn more about the disease's progression, symptoms and mortality.
Over the last two centuries electrical microstimulation has been often used to demonstrate causal links between neural activity and specific behaviors or cognitive functions. However, to understand the mechanisms by which electrical microstimulation can cause alternations in behaviors and cognitive functions it is imperative to characterize the cortical activity patterns that are elicited by stimulation locally around the electrode and in other functionally connected areas.
Banyan Biomarkers, Inc., a pioneer in developing biomarkers for traumatic brain injury (TBI), today announced the publication of the results for the ALERT-TBI study, an international, multicenter clinical trial utilizing the Banyan Brain Trauma Indicator.
› Verified 6 days ago